AI-powered music therapy · Cancer care

Music that
listens back.

MeloMend reads a chemotherapy patient's brain and body in real time — then composes personalized, therapeutic music that eases distress and protects cognitive health, session after session.

See how it works

Grounded in peer-reviewed research · Built for Abu Dhabi's digital-health ecosystem

Live session · patient state

Sensing → Understanding → Adapting

EEGFused
HRVStable
Skin ConductanceReading
Agentic LayerPlanning
75%
of patients experience "chemo brain" — cognitive impairment during chemotherapy
~50%
report clinically significant psychological distress during treatment
35M
new cancer cases projected annually by 2050, up from 20M in 2022
18.1M
cancer survivors alive today who may carry lasting cognitive effects
Who we serve

Built for the people treating cancer, not just the patients living with it.

MeloMend installs into the environments where chemotherapy actually happens, extending specialist-grade support to every chair, every ward, every shift.

Oncology hospitals & cancer centers

Add specialist-grade psychological and cognitive support to every infusion chair, without adding headcount.

Chemotherapy day clinics & infusion units

Give patients real-time relief during the exact hours distress and cognitive strain peak.

Psycho-oncology & rehabilitation programs

Extend continuity of care beyond the session with a take-home, personalized playlist.

Healthcare systems & digital-health portfolios

Integrate biometric session data directly into the patient's clinical record.

How it works

From brainwave to melody, in real time.

01 · Sense

Continuous, non-invasive biosensing

A dry-sensor EEG headband and a medical-grade wristband capture brain activity, heart-rate variability and skin conductance throughout the infusion session.

02 · Understand

Multimodal AI fusion

A transformer-based EEG Conformer fuses every signal into one real-time read of emotional and cognitive state, while an agentic layer plans the session around the patient's history and progress.

03 · Adapt

Personalized, adaptive music

The system composes music tailored to that state — targeting the neural circuits behind mood regulation and cognitive recovery, moment to moment.

MeloMend is built to work alongside your clinical team, not around it.

About MeloMend

A therapeutic partner built at the intersection of neuroscience, AI, and music.

MeloMend was founded to close a gap that conventional cancer care has never fully addressed: the psychological and cognitive toll of chemotherapy itself. We combine real-time biometric sensing with a goal-directed AI layer to bring specialist-grade support to patients exactly when — and where — they need it most, under the oversight of the clinicians who care for them.

Mission

Support every patient, not just the ones who can reach a specialist.

To give every cancer patient access to specialist-grade psychological and cognitive support — during the exact moments chemotherapy makes it hardest to cope — regardless of how few trained therapists are available where they're being treated.

Vision

A standard of care, not a novelty.

A future where AI-composed, biometrically adaptive therapy is a standard part of cancer care everywhere — extending the reach of scarce specialists to every infusion chair, in every clinic that needs it, from Abu Dhabi outward.

Co-pilot, not autopilot

The agentic layer proposes and prepares; the clinician reviews, guides, and retains authority over care.

Real-time, not reactive

Support arrives during treatment, when distress and cognitive strain are highest — not after.

Evidence before assumption

Every design choice is grounded in peer-reviewed research across music therapy, neuroscience and AI.

Privacy by design

Biometric and personal data are encrypted end-to-end and handled under GDPR- and HIPAA-aligned practice from day one.

Grounded in research

MeloMend didn't invent the science — it operationalizes it.

Our approach draws on converging, peer-reviewed research: the clinical efficacy of music therapy in oncology, AI-personalized treatment, transformer-based models for neurophysiological data, multimodal biometric fusion, and the emerging use of agentic AI in healthcare.

Music therapy & oncology outcomes AI-personalized relaxation training Neuroplasticity & music Human–AI collaboration in therapy Transformer EEG models Multimodal biometric fusion Agentic AI in healthcare
Our team

A multidisciplinary team bridging the clinical and technical.

MeloMend is built by a team combining clinical neuroscience and music therapy expertise with hands-on AI, cybersecurity and cloud engineering experience.

DN

Diala Nusır

Chief Executive Officer

Leads MeloMend's strategy and execution. Certified Penetration Tester and Ethical Hacker with five years of experience, bringing security leadership that reinforces the platform's data-protection commitments.

LN

Lara Nusır

Director

Music Technology Specialist and PhD candidate in Music Sciences, providing the project's core expertise in music technology and therapeutic sound design.

RM

Assoc. Prof. Dr. Rami Malkawi

Academic Advisor

Director of the Computer and Information Center at Yarmouk University, with 11+ years of senior academic and administrative leadership.

KA

Khaled Ababneh

AI Software Developer

AI Software Engineer with a Data Science background and five years of experience developing AI software.

BH

Bahaa Haliko

Translator & Marketing

Marketing officer and multilingual (Turkish–English–Arabic) translator and content creator specializing in voiceover and advertising.

For hospitals & clinics

A turnkey therapeutic layer for your oncology ward.

MeloMend installs into your existing chemotherapy workflow — no extra headcount, no disruption to infusion schedules — and gives every patient continuous, biometrically adaptive support for the full duration of their treatment.

Sensing suite

A fault-tolerant, two-layer sensing system.

When one signal momentarily degrades — a patient shifts, tenses, or tires — the others sustain an accurate read, so therapy keeps adapting without interruption.

High-resolution neurological layer

Muse S Athena headband

A lightweight (~41g) dry-sensor EEG headband worn comfortably during infusion.

  • Seven EEG sensors across frontal & temporal regions
  • PPG sensor for heart rate
  • fNIRS sensor tracking frontal-cortex activity — a direct window into the cognitive effort behind "chemo brain"
Robust physiological baseline layer

Empatica EmbracePlus wristband

A medical-grade, wrist-worn wearable providing a stable physiological baseline.

  • Heart-rate variability from blood volume pulse
  • Electrodermal activity (skin conductance)
  • FDA 510(k)-cleared, streamed through a HIPAA-compliant pipeline
Two-layer intelligence

Perception that understands. A layer above it that acts on it.

01

Multimodal perception layer

A transformer-based EEG Conformer interprets brain activity while parallel streams process HRV and skin conductance. A multi-head cross-attention fusion mechanism combines them into a single real-time estimate of emotional and cognitive state.

02

Agentic AI layer

A goal-directed agent sets therapeutic objectives and pursues them across the full course of treatment — planning each session from patient history, self-correcting when an approach underperforms, and flagging concerning trends to the clinical team.

Why clinical teams choose MeloMend

Six innovations that set MeloMend apart from playlist-based tools.

Real-time personalization

Music adapts to EEG, HRV and stress signals live — becoming more precise with every session rather than repeating fixed playlists.

Acoustic neural stimulation

Sound frequencies are tuned to target specific brain regions, supporting cognitive flexibility against "chemo brain."

Fault-tolerant sensing

Dual-layer biosensors keep therapy responsive even when one signal source momentarily degrades.

Goal-directed therapy

The agentic layer pursues therapeutic objectives across an entire treatment course, not just a single session.

Clinician co-pilot design

The system proposes; your care team reviews, guides and retains full authority, with conservative escalation rules.

Cloud-scale deployment

Deploys across wards, clinics and treatment centers, integrating with hospital platforms so data flows into the patient record.

Implementation roadmap

From model development to commercial deployment.

01
3–6 months

AI model development & training

Collect datasets on music therapy, biometric response and emotion; train and validate the EEG Conformer and fusion models under clinical supervision.

02
6–12 months

Prototype development & integration testing

Integrate the AI model with EEG, HRV and skin-conductance sensors; build the clinical monitoring interface; run small-scale pilots in selected oncology centers.

03
12–24 months

Clinical expansion & regulatory approvals

Expand trials and hospital partnerships; engage regulatory bodies including the FDA and regional authorities while ensuring HIPAA and ISO 13485 compliance.

04
24+ months

Commercial launch & strategic expansion

Launch as a certified digital-health product; deepen integration with hospital and telehealth platforms; expand regionally and globally.

Data privacy & compliance

Built for regulated, clinical environments from day one.

All personal and biometric data is end-to-end encrypted and handled under recognized medical-device and data-protection standards.

HIPAA-aligned GDPR-aligned FDA pathway ISO 13485 DoH – Abu Dhabi Emirates Drug Establishment
Partnership models

Flexible ways to bring MeloMend to your institution.

Subscriptions

Per-ward or per-facility access to the full platform and support.

Institutional licenses

Health-system-wide deployment across multiple sites.

Research partnerships

Collaborate on clinical validation and published outcomes.

Insurance collaborations

Explore coverage pathways for complementary cancer care.

Ready to bring specialist-grade support to every infusion chair?

Contact

Bring MeloMend to your care team.

Whether you're exploring a pilot program, a research partnership, or investment, we'd love to hear from you. A member of our team will respond within two business days.

Based inAbu Dhabi, UAE — Hub71 ecosystem
Emailhello@melomend.ai
Phone+971 (0) XX XXX XXXX

Prepared for Hub71 — Abu Dhabi Global Tech Ecosystem. Contact details shown are placeholders — swap in your organization's real information before publishing.

We'll get back to you within two business days.